share_log

大摩:维持Arrowhead Pharma(ARWR.US)评级,由持股观望调整至持股观望评级, 目标价由36.00美元调整至27.00美元。

Zhitong Finance ·  May 13 12:45

大摩:维持Arrowhead Pharma(ARWR.US)评级,由持股观望调整至持股观望评级, 目标价由36.00美元调整至27.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment